Literature DB >> 28502337

Successful Treatment of Central Nervous System Vasculitis Associated with Relapsing Polychondritis With Cyclophosphamide.

Maha Almackenzie1, Ahmad Alharbi1, Sharifa Alhassan1, Eleanor Cook2, Nezam Altorok3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28502337     DOI： 10.1016/j.amjms.2016.11.023

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  4 in total

1.  Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring.

Authors:  Jun Shimizu; Yoshihisa Yamano; Kimito Kawahata; Noboru Suzuki
Journal:  BMC Rheumatol       Date:  2020-09-11

2.  Comparison of relapsing polychondritis patients with and without central nervous system involvement: A retrospective study of 181 patients.

Authors:  Xiaoyu Cao; Lixiu Zhu; Huijuan Li; Li Jiang; Dong Xu; Jiuliang Zhao; Jiaxin Zhou; Fengchun Zhang; Yong Hou; Xiaofeng Zeng
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 3.  Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases.

Authors:  Luca Seitz; Pascal Seitz; Roxana Pop; Fabian Lötscher
Journal:  Curr Rheumatol Rep       Date:  2022-09-27       Impact factor: 4.686

Review 4.  Refractory relapsing polychondritis: challenges and solutions.

Authors:  Fernando Kemta Lekpa; Xavier Chevalier
Journal:  Open Access Rheumatol       Date:  2018-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.